Roger Sawhney
Board Member
Arbutus Biopharma Corp (ABUS)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Roger Sawhney
Roger Sawhney is recorded as Board Member at Arbutus Biopharma Corp (ABUS). Arbutus Biopharma Corp reported in an 8-K filed August 6, 2025 that Roger Sawhney was appointed Board, effective August 4, 2025.
“On August 4, 2025, the Board appointed Dr. Roger Sawhney to the Board, to serve until the Company's 2026 annual general meeting of shareholders or until his successor is duly appointed and qualified, or until his earlier death, resignation or removal.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
Start not stated–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Arbutus Biopharma Corp
Other people whose current roles at this company are on record from its filings.
- Lindsay Androski CEO, Chairman, Board Member
- Mark J. Murray CEO
- Michael J. McElhaugh CEO, COO, Board Member
- Tuan Nguyen CFO
- Michael McElhaugh COO
- Mike McElhaugh COO
- J. Christopher Naftzger General Counsel
- Anuj Hasija Board Member
- Eric Venker, M.D., Pharm.D. Board Member
- Frank Torti, M.D. Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.